SEC Form 4 · accession 0001179110-19-001237
Editas Medicine, Inc. · EDIT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Vickesh Myer
Officer — Chief Technology Officer
Period of report
Jan 31, 2019
Accepted (ET)
Feb 4, 2019 · 5:32 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001650664
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | Jan 31, 2019 | A | 16,722 | A | — | — | Common Stock | 16,722 | 16,722 | D |
Explanation of responses
- F1Each restricted stock unit represents the right to receive one share of common stock of Editas Medicine, Inc.
- F2The restricted stock unit award is scheduled to vest in its entirety on January 31, 2020, subject to acceleration in specified circumstances. Vested shares will be delivered to the Reporting Person on January 31, 2020.